Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03209713
NA

Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination

Sponsor: Memorial Sloan Kettering Cancer Center

View on ClinicalTrials.gov

Summary

This study is a two-arm randomized controlled trial, implemented to assess the effectiveness of a community-based educational program with and without a text messaging reminder system, in increasing the rate of HPV vaccination completion among children of Mexican Americans. The investigator's have extended the duration that participants are followed in assessing their child's uptake of the HPV vaccine to coincide with the COVID-19 related clinic closures and/or allow flexibility for participants who decide to delay their child's vaccination for fear of exposure to the COVID-19 infection. A survey will also assess the participants concerns regarding the impact COVID-19 has had in their daily life, such as financial insecurity, food access, housing insecurity and among other most common concerns during this unprecedented time. Additional navigation, referrals and interviewer notes will also be captured. Participants may be called by site or MSK staff to complete study surveys and will be informed verbally or by a mailed letter.

Key Details

Gender

All

Age Range

21 Years - 84 Years

Study Type

INTERVENTIONAL

Enrollment

672

Start Date

2017-06-28

Completion Date

2026-06

Last Updated

2025-04-17

Healthy Volunteers

Yes

Conditions

Interventions

BEHAVIORAL

HPV Vaccine Education

A one on one twenty-minute parental educational program (in-person or over the phone) providing facts about HPV, HPV-related cancers, and the HPV vaccine.

BEHAVIORAL

Text Messaging Reminder

Participants will receive a text message reminding them of their child's vaccination eligibility once a week, starting one week after participating in the education session (in-person or over the phone). All participants randomized to the text message reminder arm will receive a welcome text message from the automated web-based text messaging service, Mosio, within 72 hours from registration. One week after receiving the welcome text message, they will receive the first weekly text messages reminding them of their child's eligibility for the first dose HPV vaccine. These weekly reminders will occur until uptake of the first dose of the vaccine is reported (through self-report outcome survey completion or submission of the HPV vaccination card/child's official immunization card) or for up to 12 weeks

Locations (4)

Alivio Medical Center

Chicago, Illinois, United States

Research, Education and Access to Community Health (REACH)

Las Vegas, Nevada, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

The University of Texas at El Paso

El Paso, Texas, United States